BioCentury
ARTICLE | Company News

Gamma Therapeutics, Health Diagnostic Laboratory deal

March 14, 2011 7:00 AM UTC

The companies partnered to jointly develop a cardiovascular disease risk diagnostic. The assay will be marketed by HDL. The assay is based on the naturally occurring clotting protein gamma prime fibr...